₹240
(Inclusive of all Taxes)
₹36.0 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
निर्माता/विपणक :
विन मेडिकेयर प्राइवेट लिमिटेड
उपभोग प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
को या उसके बाद समाप्त हो जाएगा :
Jan-27
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Mobiswift-D Tablet:
Co-administration of Mobiswift-D Tablet with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Mobiswift-D Tablet is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
Co-administration of Mobiswift-D Tablet with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Mobiswift-D Tablet is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
Severe
How does the drug interact with Mobiswift-D Tablet:
Co-administration of Mobiswift-D Tablet and Ramucirumab can cause bleeding and ulcers.
How to manage the interaction:
Co-administration of Mobiswift-D Tablet and Ramucirumab can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Mobiswift-D Tablet and Ramucirumab can cause bleeding and ulcers.
How to manage the interaction:
Co-administration of Mobiswift-D Tablet and Ramucirumab can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
DiclofenacSulindac
Severe
How does the drug interact with Mobiswift-D Tablet:
Co-administration of Mobiswift-D Tablet and sulindac can increase the risk of side effects.
How to manage the interaction:
Although there is a interaction between Mobiswift-D Tablet and sulindac, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Mobiswift-D Tablet and sulindac can increase the risk of side effects.
How to manage the interaction:
Although there is a interaction between Mobiswift-D Tablet and sulindac, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Mobiswift-D Tablet:
Co-administration of Mobiswift-D Tablet with Celecoxib may increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Although there is a interaction between Mobiswift-D Tablet and Celecoxib, but it can be taken if your doctor has advised it. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Do not discontinue any medication without consulting a doctor.
Co-administration of Mobiswift-D Tablet with Celecoxib may increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Although there is a interaction between Mobiswift-D Tablet and Celecoxib, but it can be taken if your doctor has advised it. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Do not discontinue any medication without consulting a doctor.
How does the drug interact with Mobiswift-D Tablet:
Co-administration of Mobiswift-D Tablet with tenofovir disoproxil may increase the risk of developing kidney problems.
How to manage the interaction:
There may be a possible interaction between Mobiswift-D Tablet and Tenofovir disoproxil but they can be taken together if your doctor has prescribed them. However consult your doctor immediately if you experience symptoms such as such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without first talking to your doctor.
Co-administration of Mobiswift-D Tablet with tenofovir disoproxil may increase the risk of developing kidney problems.
How to manage the interaction:
There may be a possible interaction between Mobiswift-D Tablet and Tenofovir disoproxil but they can be taken together if your doctor has prescribed them. However consult your doctor immediately if you experience symptoms such as such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without first talking to your doctor.
How does the drug interact with Mobiswift-D Tablet:
Concomitant use of Mobiswift-D Tablet with dabigatran may increase the risk of stomach bleeding.
How to manage the interaction:
Taking Mobiswift-D Tablet with dabigatran together possibly results in an interaction, it can be taken if your doctor has advised it. You should consult a doctor immediately if you experience any unusual bleeding or bruising or have other signs and symptoms of bleeding such as dizziness, light headedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache and weakness. Do not stop using any medications without first talking to your doctor.
Concomitant use of Mobiswift-D Tablet with dabigatran may increase the risk of stomach bleeding.
How to manage the interaction:
Taking Mobiswift-D Tablet with dabigatran together possibly results in an interaction, it can be taken if your doctor has advised it. You should consult a doctor immediately if you experience any unusual bleeding or bruising or have other signs and symptoms of bleeding such as dizziness, light headedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache and weakness. Do not stop using any medications without first talking to your doctor.
Severe
How does the drug interact with Mobiswift-D Tablet:
Taking acalabrutinib together with Mobiswift-D Tablet may increase the risk of bleeding.
How to manage the interaction:
Co-administration of Mobiswift-D Tablet and Acalabrutinib can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Taking acalabrutinib together with Mobiswift-D Tablet may increase the risk of bleeding.
How to manage the interaction:
Co-administration of Mobiswift-D Tablet and Acalabrutinib can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Mobiswift-D Tablet:
Taking Mobiswift-D Tablet with Tolmetin may increase the risk of side effects.
How to manage the interaction:
There may be a possible interaction between Mobiswift-D Tablet and Tolmetin but can be taken if prescribed by doctor. However, consult your doctor immediately if you experience any unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medications without consulting a doctor.
Taking Mobiswift-D Tablet with Tolmetin may increase the risk of side effects.
How to manage the interaction:
There may be a possible interaction between Mobiswift-D Tablet and Tolmetin but can be taken if prescribed by doctor. However, consult your doctor immediately if you experience any unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medications without consulting a doctor.
Severe
How does the drug interact with Mobiswift-D Tablet:
Coadministration of Mobiswift-D Tablet with cidofovir may increase the risk of kidney problems.
How to manage the interaction:
Although taking Mobiswift-D Tablet and cidofovir together can possibly cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Coadministration of Mobiswift-D Tablet with cidofovir may increase the risk of kidney problems.
How to manage the interaction:
Although taking Mobiswift-D Tablet and cidofovir together can possibly cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Mobiswift-D Tablet:
Taking Mobiswift-D Tablet with human immunoglobulin may increase the risk of kidney problems.
How to manage the interaction:
Although there is an interaction between Human immunoglobulin and Mobiswift-D Tablet, you can take these medicines together if prescribed by a doctor. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Taking Mobiswift-D Tablet with human immunoglobulin may increase the risk of kidney problems.
How to manage the interaction:
Although there is an interaction between Human immunoglobulin and Mobiswift-D Tablet, you can take these medicines together if prescribed by a doctor. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
शराब
Unsafe
मोबिस्विफ्ट-डी टैबलेट 10's लेते समय शराब का सेवन न करें क्योंकि इससे उनींदापन बढ़ सकता है। इससे पेट से खून बहने का खतरा भी बढ़ सकता है।
गर्भावस्था
Caution
यदि आपको इस संबंध में कोई चिंता हो तो कृपया अपने डॉक्टर से परामर्श करें; आपका डॉक्टर केवल तभी दवा लिखेगा जब लाभ जोखिम से अधिक होंगे।
स्तनपान
Caution
मोबिस्विफ्ट-डी टैबलेट 10's लेने से पहले अपने चिकित्सक से परामर्श करें; आपका चिकित्सक यह निर्णय लेगा कि स्तनपान कराने वाली माताओं द्वारा मोबिस्विफ्ट-डी टैबलेट 10's लिया जा सकता है या नहीं।
ड्राइविंग
Caution
मोबिस्विफ्ट-डी टैबलेट 10's से उनींदापन हो सकता है। जब तक आप सतर्क न हों, तब तक वाहन न चलाएं या मशीनरी न चलाएं।
जिगर
Caution
लीवर की खराबी वाले रोगियों में खुराक समायोजन की आवश्यकता हो सकती है। यदि आपको लीवर की खराबी है या इससे संबंधित कोई चिंता है, तो कृपया अपने डॉक्टर से परामर्श करें।
किडनी
Caution
गुर्दे की खराबी वाले रोगियों में खुराक समायोजन की आवश्यकता हो सकती है। यदि आपको गुर्दे की खराबी है या इस बारे में कोई चिंता है तो कृपया अपने डॉक्टर से परामर्श करें।
बच्चे
Unsafe
मोबिस्विफ्ट-डी टैबलेट 10's को बच्चों को नहीं दिया जाना चाहिए क्योंकि इसकी सुरक्षा और प्रभावशीलता स्थापित नहीं हुई है।
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
